Molecular Tumor Board Helps in Advanced Cancer Cases

With accelerating development of personalized cancer treatments matched to a patient’s DNA sequencing, proponents say frontline physicians increasingly need help to maneuver through the complex genomic landscape to find the most effective, individualized therapy.

In a paper published in the May 5 online issue of The Oncologist, researchers at the University of California, San Diego School of Medicine and Moores Cancer Center detail their experience evaluating 34 patients between December 2012 and June 2013 using a molecular tumor board – a new type of advisory group comprised of multidisciplinary experts, including those in the fields of tumor genetics, basic science and bioinformatics. … Read the full story from the UC San Diego Newsroom

Cancer Cells Co-opt Immune Response to Escape Destruction

Researchers at the University of California, San Diego School of Medicine report that tumor cells use stress signals to subvert responding immune cells, exploiting them to actually boost conditions beneficial to cancer growth. … Read the full story from the UCSD Newsroom


Dr. Maurizio ZanettiThe report comes from the laboratory of Dr. Maurizio Zanetti (left), with graduate student Navin R. Mahadevan as lead author and Dr. Zanetti as senior author.

Maurizio Zanetti, MD, is emeritus professor of medicine in the Division of Hematology-Oncology and director of the Laboratory of Immunology at the UCSD Moores Cancer Center.

Dr. Zanetti is the director of tumor immunology for the UCSD Center for Immunology, Infection and Inflammation.  He directs the immunology course in the Biomedical Sciences graduate program.

Drs. Zanetti and Mahadevan published a Science Magazine Perspectives article on the connection between immune surveillance and chromosomal chaos in September.

On the PLOS ONE report, coauthors from Dr. Zanetti’s laboratory are undergraduate student Veronika Anufreichik, graduate student Jeffrey J. Rodvold and research associate Kevin T. Chiu.

Read the report in PLOS ONE

Citation for the report:  Mahadevan NR, Anufreichik V, Rodvold JJ, Chiu KT, Sepulveda H, et al. (2012) Cell-Extrinsic Effects of Tumor ER Stress Imprint Myeloid Dendritic Cells and Impair CD8+ T Cell Priming. PLoS ONE 7(12): e51845. doi:10.1371/journal.pone.0051845

More Information:

  • Science Magazine Perspectives article, September 2012:

Zanetti M, Mahadevan NR. Immune Surveillance from Chromosomal Chaos? Science 337 (6102): 1616-1617, 28 September 2012. DOI: 10.1126/science.1228464.

  • Other UCSD news stories about Dr. Zanetti’s work:
  • Related Links: